| P2093 | author name string | Bjorn R Olsen | |
| | Damian Medici | |
| P2860 | cites work | Transcriptional regulation of vascular endothelial cell responses to hypoxia by HIF-1. | Q51614218 |
| | Hypoxia-Inducible Factor-1 (HIF-1) | Q61645733 |
| | Pediatric utilization of rapamycin for severe cardiac allograft rejection | Q74191605 |
| | Functions of the VEGF receptor-1 (FLT-1) in the vasculature | Q76385039 |
| | Images in clinical medicine. Facial angiofibromas associated with tuberous sclerosis | Q83629970 |
| | Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1 | Q24316075 |
| | Rapamycin and mTOR kinase inhibitors | Q24644623 |
| | Targeting the PI3K signaling pathway in cancer | Q24647554 |
| | The phosphoinositide 3-kinase pathway | Q27860738 |
| | HIF-1: mediator of physiological and pathophysiological responses to hypoxia | Q28140835 |
| | Hypoxia-inducible factor (HIF-1)alpha: its protein stability and biological functions | Q28251400 |
| | Topical rapamycin therapy to alleviate the cutaneous manifestations of tuberous sclerosis complex: a double-blind, randomized, controlled trial to evaluate the safety and efficacy of topically applied rapamycin | Q33403043 |
| | P70S6K 1 regulation of angiogenesis through VEGF and HIF-1alpha expression | Q34083360 |
| | mTOR-targeted therapy of cancer with rapamycin derivatives | Q34397003 |
| | Hypoxia-induced mediators of stem/progenitor cell trafficking are increased in children with hemangioma | Q34687930 |
| | Conversion of vascular endothelial cells into multipotent stem-like cells | Q35532554 |
| | Immunosuppressive drug monitoring of sirolimus and cyclosporine in pediatric patients | Q35795977 |
| | mTOR, translational control and human disease. | Q36013966 |
| | Clonality and altered behavior of endothelial cells from hemangiomas. | Q36163041 |
| | Suppressed NFAT-dependent VEGFR1 expression and constitutive VEGFR2 signaling in infantile hemangioma | Q36995485 |
| | Loss of HIF-1alpha in endothelial cells disrupts a hypoxia-driven VEGF autocrine loop necessary for tumorigenesis. | Q46033311 |
| | Silibinin inhibits hypoxia-inducible factor-1alpha and mTOR/p70S6K/4E-BP1 signalling pathway in human cervical and hepatoma cancer cells: implications for anticancer therapy | Q46268730 |
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 8 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | sirolimus | Q32089 |
| | endothelium | Q111140 |
| P304 | page(s) | e42913 | |
| P577 | publication date | 2012-08-10 | |
| P1433 | published in | PLOS One | Q564954 |
| P1476 | title | Rapamycin inhibits proliferation of hemangioma endothelial cells by reducing HIF-1-dependent expression of VEGF. | |
| | Retracted: Rapamycin Inhibits Proliferation of Hemangioma Endothelial Cells by Reducing HIF-1-Dependent Expression of VEGF | |
| P478 | volume | 7 | |